| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/04/2006 | EP1611094A1 Pyrazole compounds |
| 01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610792A1 Calcium channel blockers comprising two benzhydril moieties |
| 01/04/2006 | EP1610786A1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 01/04/2006 | EP1610776A2 Ophthalmic compositions for treating ocular hypertension |
| 01/04/2006 | EP1610774A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1351688A4 Urotensin-ii receptor antagonists |
| 01/04/2006 | EP1339677B1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP0885885B1 Pyridone derivatives and herbicides |
| 01/04/2006 | CN1717404A 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/04/2006 | CN1717403A Process for preparing optically pure active compounds |
| 01/04/2006 | CN1717402A Process for preparing (s)-pantoprazole |
| 01/04/2006 | CN1717401A Anilinopyrazole derivatives useful for the treatment of diabetes |
| 01/04/2006 | CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 01/04/2006 | CN1717393A Pyrazole derivatives useful as COX-I inhibitors |
| 01/04/2006 | CN1717392A Enantioselective alkylation of tricyclic compounds |
| 01/04/2006 | CN1717391A Inhibitors of glycogen synthase kinase 3 |
| 01/04/2006 | CN1717389A Phenyl substituted piperidine compounds for use as PPAR activators |
| 01/04/2006 | CN1717250A Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1234705C New hydroxyl indoles, their use as phosphor diesterase 4 inhibitors and method for producing same |
| 01/04/2006 | CN1234694C New imidazoline compound, its preparation method and drug composition containing them |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234679C Shortened synthesis of 3, 3-diaryl propylamine derivatives |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982275 Oxidizing a benzylthio- or pyridylmethylthio-substituted indole or benzimidazole derivative |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982268 Useful in the treatment of a variety of central nervous system disorders in humans including anxiety, depression, sleep disorders, attention deficit disorder, or Alzheimer's dementia |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | US6982266 N-(4-indol-5-yloxyphenyl){4-[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]piperazinyl}carboxamide for example; antiproliferative agents which inhibit phosphorylation of kinases such as tyrosine kinase; cancer, arteriosclerosis |
| 01/03/2006 | US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 01/03/2006 | CA2162463C Azolylamine derivative |
| 01/02/2006 | WO2006010641A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 01/02/2006 | CA2571323A1 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 12/29/2005 | WO2005123746A1 Methods for preparation of levofloxacin and ofloxacin |
| 12/29/2005 | WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides |
| 12/29/2005 | WO2005123724A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 12/29/2005 | WO2005123723A1 3-cycloalkylbenzazepines as histamine h3 antagonists |
| 12/29/2005 | WO2005123719A1 Compounds and compositions as protein kinase inhibitors |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123717A1 7-pyrazolylbenzazepines having affinity for d3 receptor |
| 12/29/2005 | WO2005123716A1 Indole derivatives as histamine receptor antagonists |
| 12/29/2005 | WO2005123715A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123714A1 Quinazoline compounds and their use in mch-related disease |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123696A1 Substituted quinazolones as anti-cancer agents |
| 12/29/2005 | WO2005123695A1 Process for producing iminoquinazolinone derivative |
| 12/29/2005 | WO2005123693A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | WO2005123692A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | WO2005123691A1 Novel cis-imidazolines |
| 12/29/2005 | WO2005123688A2 3-aminoindazoles |
| 12/29/2005 | WO2005123687A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 12/29/2005 | WO2005123686A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 12/29/2005 | WO2005123680A1 Six-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005123675A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123674A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123673A1 Indoles useful in the treatment of inflammation |
| 12/29/2005 | WO2005123672A2 Kinase inhibitors |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/29/2005 | WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005123033A2 Fine particles of cilostazol and processes for production thereof |
| 12/29/2005 | WO2005105780A3 Compositions useful as inhibitors of rock and other protein kinases |
| 12/29/2005 | WO2005086656A3 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 12/29/2005 | WO2005007625A3 Heterocyclic amides with anti-tuberculosis activity |
| 12/29/2005 | US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 12/29/2005 | US20050288354 peroxisome proliferator activated receptor scaffold and modulator; 3-[1-(4-butoxy-benzenesulfonyl)-5-metoxy-1H-indol-3-yl]-propionic acid methyl etster; for identification or development of additional active compound; bioassay: binding affinity or specificity; antidiabetic, obesity, metabolic disorder |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288347 Certain triazole-based compounds, compositions, and uses thereof |
| 12/29/2005 | US20050288344 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288335 Triamide-substituted heterobicyclic compounds |
| 12/29/2005 | US20050288334 preparing an optically pure proton pump inhibitor having a sulfinyl structure using a chiral zirconium complex or a chiral hafnium complex; comprising oxidizing a corresponding sulfide |
| 12/29/2005 | US20050288332 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2ylmethyl)piperidin-4-yl]-1h- pyrrole mono-hydrochloride |
| 12/29/2005 | US20050288327 Small molecule inhibitors of HER2 expression |
| 12/29/2005 | US20050288324 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
| 12/29/2005 | US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288317 Amido compounds and their use as pharmaceuticals |
| 12/29/2005 | US20050288314 2,4-diaminoquinazolines for spinal muscular atrophy |
| 12/29/2005 | US20050288308 11B-HSD1 inhibitors for the treatment of diabetes |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288297 {4-[6-methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl]piperazinyl}-N-[4-(methylethoxy)phenyl]carboxamide; inhibits phosphorylation of platelet-derived growth factor receptor to hinder abnormal cell growth/wandering; cancer; arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis |
| 12/29/2005 | US20050288286 Anti-inflammatory medicaments |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288278 HIV replication inhibiting pyrimidines |
| 12/29/2005 | US20050288275 New compounds |
| 12/29/2005 | US20050288271 Arylsulfonamides and uses related thereto |
| 12/29/2005 | US20050288233 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |